| Market Cap | ₹9,705Cr |
| ROE | 26.53% |
| P/E Ratio(TTM) | 56.63 |
| EPS(TTM) | 28.02 |
| P/B Ratio | 14.71 |
| Dividend Yield | 0.46% |
| Industry P/E | 31.53 |
| Book Value | 107.86 |
| Debt to Equity | 0.10 |
| Face Value | 10 |
| Managing Director | Niravkumar Kirtikumar Mehta |
| Founded | 2004 |
| NSE Symbol | CORONA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.30 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.54 | ||
| Wockhardt | NA (0.00%) | -2253.15 | ||
| Natco Pharma | NA (0.00%) | 9.47 |